NCT01704001View on ClinicalTrials.gov

Clinical Pharmacokinetics Study of ART-123 in Disseminated Intravascular Coagulation (DIC) Subjects With Renal Impairment

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

October 31, 2013

Study Completion Date

June 30, 2014

Conditions
Disseminated Intravascular Coagulation
Interventions
DRUG

ART-123

380 U/kg/day or 130 U/kg/day(Subjects with severe renal impairment) for 6 days

Trial Locations (1)

Unknown

Ōita

All Listed Sponsors
lead

Asahi Kasei Pharma Corporation

INDUSTRY

NCT01704001 - Clinical Pharmacokinetics Study of ART-123 in Disseminated Intravascular Coagulation (DIC) Subjects With Renal Impairment | Biotech Hunter | Biotech Hunter